167 related articles for article (PubMed ID: 37819534)
1. Good practices for the automated production of
Blok S; Wängler C; Bartenstein P; Jurkschat K; Schirrmacher R; Lindner S
EJNMMI Radiopharm Chem; 2023 Oct; 8(1):25. PubMed ID: 37819534
[TBL] [Abstract][Full Text] [Related]
2. Automated production of [
Lindner S; Simmet M; Gildehaus FJ; Jurkschat K; Wängler C; Wängler B; Bartenstein P; Schirrmacher R; Ilhan H
Nucl Med Biol; 2020; 88-89():86-95. PubMed ID: 32828007
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of a Bioorthogonal PET Tracer Candidate [
Otaru S; Niemikoski H; Sarparanta M; Airaksinen AJ
Mol Pharm; 2020 Aug; 17(8):3106-3115. PubMed ID: 32539414
[TBL] [Abstract][Full Text] [Related]
4. Radiosynthesis of [
Lindner S; Wängler C; Bailey JJ; Jurkschat K; Bartenstein P; Wängler B; Schirrmacher R
Nat Protoc; 2020 Dec; 15(12):3827-3843. PubMed ID: 33230332
[TBL] [Abstract][Full Text] [Related]
5. One-step ¹⁸F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET).
Wängler C; Waser B; Alke A; Iovkova L; Buchholz HG; Niedermoser S; Jurkschat K; Fottner C; Bartenstein P; Schirrmacher R; Reubi JC; Wester HJ; Wängler B
Bioconjug Chem; 2010 Dec; 21(12):2289-96. PubMed ID: 21082773
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in the Clinical Translation of Silicon Fluoride Acceptor (SiFA)
Gower-Fry L; Kronemann T; Dorian A; Pu Y; Jaworski C; Wängler C; Bartenstein P; Beyer L; Lindner S; Jurkschat K; Wängler B; Bailey JJ; Schirrmacher R
Pharmaceuticals (Basel); 2021 Jul; 14(7):. PubMed ID: 34358127
[TBL] [Abstract][Full Text] [Related]
7. Automated synthesis of [
Wurzer A; Di Carlo D; Herz M; Richter A; Robu S; Schirrmacher R; Mascarin A; Weber W; Eiber M; Schwaiger M; Wester HJ
EJNMMI Radiopharm Chem; 2021 Jan; 6(1):4. PubMed ID: 33484364
[TBL] [Abstract][Full Text] [Related]
8. Silicon-Fluoride Acceptors (SiFA) for
Gower-Fry L; Wängler C; Bartenstein P; Beyer L; Lindner S; Jurkschat K; Wängler B; Bailey JJ; Schirrmacher R
Methods Mol Biol; 2024; 2729():29-43. PubMed ID: 38006489
[TBL] [Abstract][Full Text] [Related]
9. ¹⁸F-labeled silicon-based fluoride acceptors: potential opportunities for novel positron emitting radiopharmaceuticals.
Bernard-Gauthier V; Wängler C; Schirrmacher E; Kostikov A; Jurkschat K; Wängler B; Schirrmacher R
Biomed Res Int; 2014; 2014():454503. PubMed ID: 25157357
[TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET.
Niedermoser S; Chin J; Wängler C; Kostikov A; Bernard-Gauthier V; Vogler N; Soucy JP; McEwan AJ; Schirrmacher R; Wängler B
J Nucl Med; 2015 Jul; 56(7):1100-5. PubMed ID: 25977461
[TBL] [Abstract][Full Text] [Related]
12. From Unorthodox to Established: The Current Status of (18)F-Trifluoroborate- and (18)F-SiFA-Based Radiopharmaceuticals in PET Nuclear Imaging.
Bernard-Gauthier V; Bailey JJ; Liu Z; Wängler B; Wängler C; Jurkschat K; Perrin DM; Schirrmacher R
Bioconjug Chem; 2016 Feb; 27(2):267-79. PubMed ID: 26566577
[TBL] [Abstract][Full Text] [Related]
13. Taking cyclotron
Nelson BJB; Wilson J; Richter S; Duke MJM; Wuest M; Wuest F
Nucl Med Biol; 2020; 80-81():24-31. PubMed ID: 32004935
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Organo [
Otaru S; Imlimthan S; Sarparanta M; Helariutta K; Wähälä K; Airaksinen AJ
Molecules; 2020 Mar; 25(5):. PubMed ID: 32156020
[TBL] [Abstract][Full Text] [Related]
15. Next Generation of SiFAlin-Based TATE Derivatives for PET Imaging of SSTR-Positive Tumors: Influence of Molecular Design on In Vitro SSTR Binding and In Vivo Pharmacokinetics.
Litau S; Niedermoser S; Vogler N; Roscher M; Schirrmacher R; Fricker G; Wängler B; Wängler C
Bioconjug Chem; 2015 Dec; 26(12):2350-9. PubMed ID: 26420336
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Preclinical Evaluation of [
Bailey JJ; Wuest M; Wagner M; Bhardwaj A; Wängler C; Wängler B; Valliant JF; Schirrmacher R; Wuest F
J Med Chem; 2021 Nov; 64(21):15671-15689. PubMed ID: 34672630
[TBL] [Abstract][Full Text] [Related]
17. 18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor (SiFA) for Positron Emission Tomography.
Connolly D; Bailey JJ; Ilhan H; Bartenstein P; Wängler C; Wängler B; Wuest M; Wuest F; Schirrmacher R
J Vis Exp; 2020 Jan; (155):. PubMed ID: 31984969
[TBL] [Abstract][Full Text] [Related]
18. One-step (18)F-labeling of peptides for positron emission tomography imaging using the SiFA methodology.
Wängler C; Niedermoser S; Chin J; Orchowski K; Schirrmacher E; Jurkschat K; Iovkova-Berends L; Kostikov AP; Schirrmacher R; Wängler B
Nat Protoc; 2012 Nov; 7(11):1946-55. PubMed ID: 23037309
[TBL] [Abstract][Full Text] [Related]
19. t-Bu2SiF-derivatized D2-receptor ligands: the first SiFA-containing small molecule radiotracers for target-specific PET-imaging.
Iovkova-Berends L; Wängler C; Zöller T; Höfner G; Wanner KT; Rensch C; Bartenstein P; Kostikov A; Schirrmacher R; Jurkschat K; Wängler B
Molecules; 2011 Sep; 16(9):7458-79. PubMed ID: 21892125
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of p-(di-tert-butyl[(18)F]fluorosilyl)benzaldehyde ([(18)F]SiFA-A) with high specific activity by isotopic exchange: a convenient labeling synthon for the (18)F-labeling of N-amino-oxy derivatized peptides.
Schirrmacher E; Wängler B; Cypryk M; Bradtmöller G; Schäfer M; Eisenhut M; Jurkschat K; Schirrmacher R
Bioconjug Chem; 2007; 18(6):2085-9. PubMed ID: 18030993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
